Top pharmaceutical, biotechnology, and regulatory thought leaders convene each January to discuss new and updated legislation in various ICH regions, current regulatory framework for pharmacovigilance in global regions, operational challenges of implementing global Benefit-risk analyses and risk management plans, the impact of social media, and the role of epidemiology in safety analysis.
- FDA Updates
- EU Regulations – Regulatory Overview
- Drug Safety in China
- Benefit-Risk and Risk Management Patient Perspective
- Real World Evidence
- Social Media
- Patient Perspective
“This conference offers a good overview of everything going on regard PV/RMP globally and is also very useful for people like me in Global Medical Affairs who are contributors and collaborators with PV/RMP groups” - Dr. Claudia Schoenig-Diesing, Baxter Healthcare Corp.
“Great program. Helps to stay on the top of new regulations.” - Cherif Benattia, Sunovion